More than 53,000 peer-reviewed studies now exist on cannabis, yet NHS prescriptions remain severely limited as UK regulators say there isn’t sufficient evidence to prescribe it more widely on the NHS.
Kirsten Curry started Leading Retirement Solutions on a core principle: everybody deserves access to investment options such as 401ks. With... read more
Oxford University researchers found no evidence that cannabis use accelerates cognitive decline or increases dementia risk in later life, according... read more
When his home state of Illinois began the transition from a medical-only market to allowing adult-use sales, Vib Gupta saw... read more
Cannabis industry professionals give their thoughts on the cannabis market in general. Some states (New York, Maryland, etc.) are still... read more
The country’s medicines regulator has approved its first psychiatrist to prescribe psilocybin for treatment-resistant depression outside of clinical trials, providing... read more
New research comparing data from Germany and Austria reveals that the legalisation of cannabis has not led to a measurable... read more
Research involving over 130,000 people reveals genetic variants associated with brain signalling and impulsivity may also influence cannabis use patterns. read more
Large study reveals no "hangover" effects, suggesting benefits are acute rather than long lasting, and that those with prior full-dose... read more
A growing number of studies find that cannabis has clear benefits for pain relief, but then refuse to recommend it... read more
A comprehensive survey of 1,450 chronic pain patients found that 86% reported moderate to significant pain improvement after using medical... read more
